DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
| You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
| To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
U.S. Physician Survey Illustrates the Devastating Impact of Thyroid Eye Disease on Patient Quality of Life
Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease (TED) to have a significant burden on their patients’ quality of life (QOL). TED is a serious, progressive and vision-threatening rare autoimmune disease associated with proptosis (eye bulging), diplopia (double vision), blurred vision, pain, inflammation and facial disfigurement. The analysis was accepted as a poster presentation at the American Association of Clinical Endocrinologists (AACE) 29th Annual Scientific & Clinical Congress and was published in a special supplement of Endocrine Practice.
“This analysis shows that physicians are acutely aware of the significant burden TED has on their patients, including not only the painful eye symptoms, but also the major impact on mental health, social interactions, driving and employment,” said Yao Wang M.D., neuro-ophthalmology and oculoplastics specialist, Cedars-Sinai Medical Center.
myBinderRelated Content
-
People & PlacesAnthony Maloof, MBBS hons, MBiomedE, FRANZCODr. Maloof is an internationally recogni...
-
Evidence & EducationManejo Quirúrgico de la Enfermedad de Graves• La tiroidectomía puede considerarse...
-
News & MeetingsPrevent Blindness Art Therapy ProgramPrevent Blindness is excited to announce...
-
News & MeetingsFDA Committee Unanimously Recommends Approval of Teprotumumab for Thyroid Eye DiseaseThe Dermatologic and Ophthalmic Drugs Ad...
-
People & PlacesIllinois Eye and Ear Infirmary – Illinois Center for Thyroid Eye DiseaseThe Illinois Center for Thyroid Eye Dise...
-
Evidence & EducationDoes Early Response to Intravenous Glucocorticoids Predict the Final Outcome in Patients With Moderate-To-Severe and...Purpose: Intravenous glucocorticoids (i...
-
Evidence & EducationKnowledge of Thyroid Eye Disease in Graves’ Disease Patients With and Without OrbitopathyBackground: Thyroid eye disease (TED) d...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.